APA

Parker W. A. E., Orme R. C., Hanson J., Stokes H. M., Bridge C. M., Shaw P. A., Sumaya W., Thorneycroft K., Petrucci G., Porro B., Judge H. M., Ajjan R. A., Rocca B. & Storey R. F. (20190417). Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. : Platelets.

Chicago

Parker William A E, Orme Rachel C, Hanson Jessica, Stokes Hannah M, Bridge Claire M, Shaw Patricia A, Sumaya Wael, Thorneycroft Kirstie, Petrucci Giovanna, Porro Benedetta, Judge Heather M, Ajjan Ramzi A, Rocca Bianca and Storey Robert F. 20190417. Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. : Platelets.

Harvard

Parker W. A. E., Orme R. C., Hanson J., Stokes H. M., Bridge C. M., Shaw P. A., Sumaya W., Thorneycroft K., Petrucci G., Porro B., Judge H. M., Ajjan R. A., Rocca B. and Storey R. F. (20190417). Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. : Platelets.

MLA

Parker William A E, Orme Rachel C, Hanson Jessica, Stokes Hannah M, Bridge Claire M, Shaw Patricia A, Sumaya Wael, Thorneycroft Kirstie, Petrucci Giovanna, Porro Benedetta, Judge Heather M, Ajjan Ramzi A, Rocca Bianca and Storey Robert F. Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. : Platelets. 20190417.